FDA Approves Unknown Drug — CASPER PHARMA LLC
Casper Pharma LLC has secured FDA approval for its generic drug application (NDA212927), slated for issuance on June 2, 2026. This regulatory clearance is expected to alter market dynamics by introducing competitive pricing for the related generic product.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day